Literature DB >> 16005434

Differential regulation of NPR-B/GC-B by protein kinase c and calcium.

Sarah E Abbey-Hosch1, Dmitri Smirnov, Lincoln R Potter.   

Abstract

C-type natriuretic peptide (CNP) activation of the guanylyl cyclase-linked natriuretic peptide receptor-B (NPR-B) stimulates vasorelaxation and bone growth. Hormones and phorbol esters (PMA) inhibit NPR-B in calcium and protein kinase c-dependent manners, respectively. Here, we characterize the kinetic properties of NPR-B in membranes from cells exposed to PMA, the calcium ionophore, ionomycin, or sphingosine-1-phosphate (S1P). PMA and ionomycin primarily increased the K(m) and decreased the V(max) of NPR-B for GTP, respectively, whereas S1P caused modest changes in both parameters. PMA and S1P treatment increased the EC50 for CNP activation by eight- and three-fold, whereas ionomycin was ineffective. All three agents caused NPR-B dephosphorylation, but the basis for the loss of phosphate differed between treatments. In vitro phosphorylation of NPR-B in membranes was markedly diminished by prior whole cell PMA or S1P exposure, whereas ionomycin pretreatment had no effect. The involvement of the known phosphorylated residues in each process was tested with a mutant receptor containing glutamates substituted for these sites. While the effect of PMA was lost on this receptor, the effects of S1P and ionomycin were only partially blocked. Our data suggest that the molecular bases for PMA- and calcium-dependent inhibition of NPR-B are unique. The former results from reduced phosphorylation of a known site and primarily affects the affinity of NPR-B for CNP and GTP. The latter is associated with reductions in maximal velocities by a mechanism that does not involve inhibition of NPR-B phosphorylation and requires a process in addition to the dephosphorylation of the known sites.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16005434     DOI: 10.1016/j.bcp.2005.04.034

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  19 in total

Review 1.  Regulation and therapeutic targeting of peptide-activated receptor guanylyl cyclases.

Authors:  Lincoln R Potter
Journal:  Pharmacol Ther       Date:  2010-12-24       Impact factor: 12.310

2.  Mass spectrometric identification of phosphorylation sites in guanylyl cyclase A and B.

Authors:  Andrea R Yoder; Matthew D Stone; Timothy J Griffin; Lincoln R Potter
Journal:  Biochemistry       Date:  2010-11-08       Impact factor: 3.162

3.  Dephosphorylation and inactivation of NPR2 guanylyl cyclase in granulosa cells contributes to the LH-induced decrease in cGMP that causes resumption of meiosis in rat oocytes.

Authors:  Jeremy R Egbert; Leia C Shuhaibar; Aaron B Edmund; Dusty A Van Helden; Jerid W Robinson; Tracy F Uliasz; Valentina Baena; Andreas Geerts; Frank Wunder; Lincoln R Potter; Laurinda A Jaffe
Journal:  Development       Date:  2014-09       Impact factor: 6.868

4.  Catalytically Active Guanylyl Cyclase B Requires Endoplasmic Reticulum-mediated Glycosylation, and Mutations That Inhibit This Process Cause Dwarfism.

Authors:  Deborah M Dickey; Aaron B Edmund; Neil M Otto; Thomas S Chaffee; Jerid W Robinson; Lincoln R Potter
Journal:  J Biol Chem       Date:  2016-03-15       Impact factor: 5.157

5.  The indolocarbazole, Gö6976, inhibits guanylyl cyclase-A and -B.

Authors:  Jerid W Robinson; Xiaoying Lou; Lincoln R Potter
Journal:  Br J Pharmacol       Date:  2011-09       Impact factor: 8.739

6.  ATP potentiates competitive inhibition of guanylyl cyclase A and B by the staurosporine analog, Gö6976: reciprocal regulation of ATP and GTP binding.

Authors:  Jerid W Robinson; Lincoln R Potter
Journal:  J Biol Chem       Date:  2011-08-02       Impact factor: 5.157

7.  A human skeletal overgrowth mutation increases maximal velocity and blocks desensitization of guanylyl cyclase-B.

Authors:  Jerid W Robinson; Deborah M Dickey; Kohji Miura; Toshimi Michigami; Keiichi Ozono; Lincoln R Potter
Journal:  Bone       Date:  2013-07-01       Impact factor: 4.398

8.  Luteinizing hormone reduces the activity of the NPR2 guanylyl cyclase in mouse ovarian follicles, contributing to the cyclic GMP decrease that promotes resumption of meiosis in oocytes.

Authors:  Jerid W Robinson; Meijia Zhang; Leia C Shuhaibar; Rachael P Norris; Andreas Geerts; Frank Wunder; John J Eppig; Lincoln R Potter; Laurinda A Jaffe
Journal:  Dev Biol       Date:  2012-04-21       Impact factor: 3.582

9.  Guanylyl cyclases A and B are asymmetric dimers that are allosterically activated by ATP binding to the catalytic domain.

Authors:  Jerid W Robinson; Lincoln R Potter
Journal:  Sci Signal       Date:  2012-09-04       Impact factor: 8.192

10.  Regulation of the Natriuretic Peptide Receptor 2 (Npr2) by Phosphorylation of Juxtamembrane Serine and Threonine Residues Is Essential for Bifurcation of Sensory Axons.

Authors:  Hannes Schmidt; Deborah M Dickey; Alexandre Dumoulin; Marie Octave; Jerid W Robinson; Ralf Kühn; Robert Feil; Lincoln R Potter; Fritz G Rathjen
Journal:  J Neurosci       Date:  2018-09-24       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.